GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptorum Group Ltd (NAS:APM) » Definitions » Days Inventory

Aptorum Group (Aptorum Group) Days Inventory : 0.00 (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Aptorum Group Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Aptorum Group's Average Total Inventories for the six months ended in Dec. 2023 was $0.00 Mil. Aptorum Group's Cost of Goods Sold for the six months ended in Dec. 2023 was $-0.01 Mil.

The historical rank and industry rank for Aptorum Group's Days Inventory or its related term are showing as below:

APM' s Days Inventory Range Over the Past 10 Years
Min: 9.38   Med: 14.03   Max: 35.58
Current: 25.14

During the past 7 years, Aptorum Group's highest Days Inventory was 35.58. The lowest was 9.38. And the median was 14.03.

APM's Days Inventory is ranked better than
92.97% of 654 companies
in the Biotechnology industry
Industry Median: 191.745 vs APM: 25.14

Aptorum Group's Days Inventory declined from Dec. 2022 (7.73) to Dec. 2023 (0.00).

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.


Aptorum Group Days Inventory Historical Data

The historical data trend for Aptorum Group's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptorum Group Days Inventory Chart

Aptorum Group Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Inventory
Get a 7-Day Free Trial 14.94 13.11 9.38 9.61 24.33

Aptorum Group Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.59 11.36 7.73 12.00 -

Competitive Comparison of Aptorum Group's Days Inventory

For the Biotechnology subindustry, Aptorum Group's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aptorum Group's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aptorum Group's Days Inventory distribution charts can be found below:

* The bar in red indicates where Aptorum Group's Days Inventory falls into.



Aptorum Group Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Aptorum Group's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

Days Inventory (A: Dec. 2023 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2022 ) + Total Inventories (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (0.028 + 0) / 1 ) / 0.42*365
=0.028 / 0.42*365
=24.33

Aptorum Group's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:

Days Inventory (Q: Dec. 2023 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Jun. 2023 ) + Total Inventories (Q: Dec. 2023 )) / count ) / Cost of Goods Sold (Q: Dec. 2023 )*Days in Period
=( (0 + 0) / 1 ) / -0.005*365 / 2
=0 / -0.005*365 / 2
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aptorum Group  (NAS:APM) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Aptorum Group's Inventory Turnover for the six months ended in Dec. 2023 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Aptorum Group's Inventory to Revenue for the six months ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Aptorum Group Days Inventory Related Terms

Thank you for viewing the detailed overview of Aptorum Group's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


Aptorum Group (Aptorum Group) Business Description

Traded in Other Exchanges
N/A
Address
17 Hanover Square, London, GBR, W1S 1BN
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.

Aptorum Group (Aptorum Group) Headlines

From GuruFocus